A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Boyce, Ross M.
    • Affiliation: School of Medicine, Division of Infectious Diseases
  • Shook-Sa, Bonnie E.
    • Affiliation: Gillings School of Global Public Health, Department of Biostatistics
  • Aiello, Allison E.
    • Affiliation: Gillings School of Global Public Health, Department of Epidemiology
Abstract
  • The COVID-19 pandemic is arguably the most important public health crisis of the last century. To date, infections with the SARS-CoV-2 virus have caused nearly 300,000 deaths in the United States alone [1], while also contributing to substantial excess morbidity and mortality from delayed and deferred care [2]. In addition to the direct and indirect health impacts, policies intended to limit the spread of the disease have resulted in large-scale disruptions to education systems, economic activity, and social networks. Put simply, the COVID-19 pandemic has impacted the daily lives of nearly all Americans in a way that no other health crisis has in our lifetimes.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Clinical Infectious Diseases
Language
  • English
Version
  • Postprint
ISSN
  •  1537-6591
Publisher
  • Oxford University Press

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details ciaa1868.pdf 2021-01-04 Public Download